Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/3025% above fair value
$19.89−0.21 (-1.04%)
Close on Nov 13, 2026Market cap $1.01BP/E –Yield –
Cryoport operating margin
Operating margin is operating income as a percentage of revenue.
Cryoport's operating margin for the twelve months ending Sep 30, 2026 was -20.0%. For fiscal 2025 it was -20.9%, against -77.6% the year before. The highest annual figure on record is -8.0% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -20.9% | +56.7 |
| FY2024 | Dec 31, 2024 | -77.6% | −18.0 |
| FY2023 | Dec 31, 2023 | -59.6% | −46.2 |
| FY2022 | Dec 31, 2022 | -13.4% | −5.4 |
| FY2021 | Dec 31, 2021 | -8.0% | +30.1 |
| FY2020 | Dec 31, 2020 | -38.1% | +13.9 |
| FY2019 | Dec 31, 2019 | -52.1% | −8.0 |
| FY2018 | Dec 31, 2018 | -44.0% | +104.6 |
| FY2016 | Mar 31, 2016 | -148.6% | −6.5 |
| FY2015 | Mar 31, 2015 | -142.1% | +48.8 |
| FY2014 | Mar 31, 2014 | -190.9% | +383.7 |
| FY2013 | Mar 31, 2013 | -574.7% | +763.4 |
| FY2012 | Mar 31, 2012 | -1338.0% | −161.0 |
| FY2011 | Mar 31, 2011 | -1177.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -17.5% | +4.9 |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -20.5% | +0.7 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -20.1% | −2.6 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -22.1% | +8.7 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -22.5% | +12.5 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -21.2% | +175.3 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -17.5% | +29.4 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -30.7% | +65.7 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -34.9% | −4.8 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -196.5% | −164.4 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -46.9% | −31.0 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -96.5% | −78.2 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -30.1% | −17.2 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -32.1% | −24.0 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -16.0% | −1.0 |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -18.3% | −3.5 |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -12.9% | −4.8 |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -8.2% | −1.5 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -14.9% | −12.8 |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -14.8% | +5.5 |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -8.1% | +88.0 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -6.7% | +55.6 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -2.1% | +34.5 |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -20.4% | −10.9 |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -96.1% | +32.8 |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -62.3% | −35.0 |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -36.7% | −4.5 |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -9.5% | +29.5 |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -128.9% | −88.0 |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -27.2% | +26.1 |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -32.2% | +12.5 |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -39.0% | +144.6 |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -40.9% | +85.9 |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -53.3% | +59.7 |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -44.7% | +124.1 |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -183.6% | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | -126.8% | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | -112.9% | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | -168.7% | – |
See a number that looks wrong?